Daewoong (003090.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7003090008
Daewoong financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.94 tn KRW | 2.07 tn KRW |
| Gross profit | 1.05 tn KRW | 1.10 tn KRW |
| Operating income | 281.91 bn KRW | 261.79 bn KRW |
| EBIT | 123.34 bn KRW | 257.48 bn KRW |
| Net income | 57.89 bn KRW | 175.06 bn KRW |
Full history since 2000, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Daewoong
Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, South Korea.
More stocks
- Zhejiang Xinzhonggang Thermal Power Co Ltd (605162.SS)
- Miquel y Costas & Miquel SA (MCM.MC)
- IntelliEPI Cayman (4971.TWO)
- Esr Kendall Square Reit Co Ltd (365550.KS)
- BlueLinx Holdings Inc. (BXC)
- ADAMAS TRUST, INC. (ADAM)
- Anhui Huaertai Chemical Co Ltd (001217.SZ)
- Surfilter Network Technology Co Ltd (300311.SZ)
- Shenzhen Water Planning & Design Institute Co. Ltd. (301038.SZ)
- Caisse Regionale De Credit Agricole Mutuel Toulouse 31 (CAT31.PA)
- Nanjing Baose Co Ltd (300402.SZ)
- Anpec Electronics (6138.TWO)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.